Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.29M Sell
14,616
-15,627
-52% -$5.35M 0.22% 102
2026
Q1
$10.6M Sell
30,243
-217
-0.7% -$77.4K 0.47% 35
2025
Q4
$10M Buy
30,460
+15,688
+106% +$4.98M 0.44% 41
2025
Q3
$4.17M Buy
14,772
+90
+0.6% +$26.1K 0.3% 62
2025
Q2
$4.1M Sell
14,682
-161
-1% -$45.6K 0.32% 59
2025
Q1
$4.63M Sell
14,843
-134
-0.9% -$39.6K 0.41% 46
2024
Q4
$3.9M Buy
+14,977
New +$4.44M 0.32% 61

Other funds holding AMGN

BFC Planning, Inc.'s AMGN Position: Q2 2026 in Review

BFC Planning, Inc. reduced its Amgen (AMGN) stake by 52% in Q2 2026, selling an estimated $5.35M and leaving 14,616 shares worth $5.29M. The position accounts for 0.22% of the portfolio, ranked #102.

BFC Planning, Inc. first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $10.6M in Q1 2026. 3,174 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • BFC Planning, Inc. held 14,616 shares of Amgen worth $5.29M as of Q2 2026.
  • BFC Planning, Inc. sold 15,627 Amgen shares in Q2 2026, an estimated $5.35M.
  • Amgen made up 0.22% of BFC Planning, Inc.'s portfolio in Q2 2026, its #102 holding.
  • BFC Planning, Inc. first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • BFC Planning, Inc.'s Amgen position peaked at $10.6M in Q1 2026.
  • 3,174 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.